News
2020.01.07
Discovering the joys of Chemistry
An eager and curious group of high school students from Sanskriti School recently visited the Sai Life Sciences R&D centre in Hyderabad to get a first-hand feel of the facilities, interact with the scientists and understand the work they do. As a company committed to building a better ecosystem of scientific talent, Sai Life Sciences […]
Read more
2019.12.31
Meet Sai Life Sciences at J.P. Morgan Healthcare Conference, San Francisco
Sai Life Sciences will be in San Francisco for the 38th Annual J.P. Morgan Healthcare Conference during January 13-16, 2020. With over two decades of working with Biotechs and advancing programs from IND to different clinical phases, we believe that we can add significant value to accelerate your NCE development. Write to us at contact@sailife.com […]
Read more
2019.12.30
Twin win for Sai Life Sciences at the CII EHS Excellence Awards
Sai Life Sciences’ focus on Sustainability received a significant fillip at the 12th edition of the Confederation of Indian Industry’s (CII-SR) EHS Excellence Awards 2019. At a glittering awards function held in December 2019, the company won two significant recognitions for its Environment, Health & Safety (EHS) practices. From a total of 174 participating companies, […]
Read more
2019.12.18
Jay Stella joins Sai Life Sciences as Chief Business Officer
Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced the appointment of Jay Stella as Chief Business Officer, to lead the overall business development and program management for the company. Jay will be based out of Cambridge, Massachusetts, United States and report to the CEO & Managing Director, […]
Read more
2019.12.12
Sai Life Sciences announces Sai Nxt, an initiative to transform the organization into a new generation CDMO
Sai Life Sciences, one of India’s fastest growing Contract Development & Manufacturing Organizations (CDMOs), today announced Sai Nxt, an organization-wide initiative aimed at transforming the company into a new generation CDMO. Guided by the insights and feedback from its customers, the company is investing upwards of US $ 150 million over the period between 2019 […]
Read more
2019.12.03
Global Business Reports interviews Krishna Kanumuri, MD & CEO Sai Life Sciences on the company’s journey of transformation
A recent edition of Global Business Reports (GBR) on India Pharmaceuticals 2019 features the interview with Krishna Kanumuri, MD & CEO of Sai Life Sciences. In the interview, Krishna provides a glimpse of the 20 years of the company, and how it is building itself for the future. Here’s an excerpt from the interview:“Sai Life […]
Read more